Glaucoma is the leading cause of irreversible blindness due to optic nerve damage and the death of retinal ganglion cells (RGCs). Presently, reducing intraocular pressure is the sole evidence-based therapy for glaucoma patients, ...
Dec 20, 2022
0
45
Deep learning plays an increasingly crucial role in biomedical research, due to its exceptional data processing capacity. However, single-feature data is far from enough to present the full picture of an issue.
Dec 15, 2022
0
5
An international team of scientists led by Mass Eye and Ear, a member of Mass General Brigham, and Boston Children's Hospital, has discovered a new genetic mutation that may be a root cause of severe cases of childhood glaucoma, ...
Dec 1, 2022
0
10
The mean length of the preclinical detectable phase (PCDP) of open-angle glaucoma is estimated to be over 10 years, according to a study published online Nov. 23 in JAMA Ophthalmology.
Nov 29, 2022
0
2
A polymer-based microshunt is safe and effective in pediatric patients with refractory childhood glaucoma, according to a small, single-center case series at the UC Davis Health Eye Center.
Nov 17, 2022
0
8
Diminishing eyesight is a common issue that occurs with age. While often unavoidable, routine eye checks are crucial.
Nov 3, 2022
0
16
Poor quality sleep, including too much or too little shuteye, daytime sleepiness, and snoring, may be linked to a heightened risk of developing irreversible sight loss (glaucoma), suggests a large UK Biobank study published ...
Nov 1, 2022
0
45
A large, nationwide study from Taiwan shows that people with a specific type of glaucoma, called normal-tension glaucoma, are at high risk for developing Alzheimer's disease. The researchers say people with this type of glaucoma ...
Sep 30, 2022
0
28
A research team led by the Department of Ophthalmology, School of Clinical Medicine, LKS Faculty of Medicine of The University of Hong Kong (HKUMed), with collaborators from the Faculty of Medicine of The Chinese University ...
Sep 9, 2022
0
60
Glaucoma is an irreversible blinding eye disease characterized by progressive ganglion cell death. To date, IOP control has been almost the only clinical option for the treatment of POAG. However, visual field damage continues ...
Aug 26, 2022
0
4
